Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Average Target Price from Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX) have earned an average rating of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $12.95.

Several research firms recently commented on AMTX. Truist Financial reaffirmed a “hold” rating and issued a $3.50 price target (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, July 31st. UBS Group reduced their price target on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research report on Monday, August 19th. Ascendiant Capital Markets decreased their target price on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd. Finally, HC Wainwright reiterated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Friday, November 15th.

Hedge Funds Weigh In On Aemetis

Hedge funds have recently modified their holdings of the business. Geode Capital Management LLC grew its holdings in shares of Aemetis by 7.7% during the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after buying an additional 66,031 shares during the last quarter. State Street Corp raised its holdings in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its position in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. Bank of New York Mellon Corp purchased a new stake in Aemetis in the 2nd quarter valued at approximately $306,000. Finally, Wellington Management Group LLP acquired a new stake in shares of Aemetis in the 3rd quarter valued at approximately $177,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Stock Performance

Shares of Aemetis stock opened at $4.10 on Friday. The company has a market cap of $203.69 million, a P/E ratio of -1.81 and a beta of 1.23. The firm has a 50-day simple moving average of $2.93 and a two-hundred day simple moving average of $3.06. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03.

Aemetis (NASDAQ:AMTX) last released its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter last year, the business earned ($0.59) EPS. Equities research analysts forecast that Aemetis will post -2.02 EPS for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.